Description

Cagrilintide is a research‑grade, long‑acting amylin‑analog peptide used exclusively for non‑clinical laboratory studies involving amylin and calcitonin receptor pathways. It is not FDA‑approved and not for human use, medical application, or therapeutic purposes.